| abstract |
Methods of treating, preventing and / or managing myelodysplastic syndromes are described. Particular methods include administering an immunomodulatory compound or a pharmaceutically acceptable salt, solvate, hydrate, stereoisomer, clathrate, or prodrug thereof, alone or in combination with a second active ingredient, and / or blood or cell transplantation. . Certain second active ingredients may affect blood cell production. Pharmaceutical compositions, single unit dosage forms, and kits suitable for use in the methods of the invention are also described. |